Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 159 for obesity

Edit search filters
  1. A Study of the Relationship of Markers of Cellular Senescence to Skeletal Parameters in Type 2 Diabetes Mellitus

    Rochester, MN

  2. Understanding The Patient Experience In Progesterone Management For Endometrial Cancer And Complex Atypical Hyperplasia

    Rochester, MN

  3. Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome

    Jacksonville, FL

  4. A Study of a Virtual Reality Module in Adolescents to Retrain their Brain to Make Healthier Choices

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  5. A Study Of Effect Of Different Biochemical Markers Including Leptin And Spexin In Children Before And After Having Hypothalamus Surgery

    Rochester, MN

  6. Phenotype-Tailored Lifestyle Intervention for Obesity

    Rochester, MN

  7. RESET System Pivotal Trial (Rev F)

    Rochester, MN

  8. A Study to Evaluate the Mechanisms Leading to Hyperoxaluria and Increased Risk of Kidney Stone Formation after Bariatric Surgery

    Rochester, MN

  9. Humans With Obesity Response to Exercise

    Rochester, MN

  10. Tradipitant After GLP-1R Agonist In Healthy, Overweight, Or Class I Or II Obese Volunteers

    Rochester, MN

.

Mayo Clinic Footer